ACRS — Aclaris Therapeutics Share News
0.000.00%
Last trade - 00:00- $628.49m
- $523.07m
- $7.83m
Aclaris Therapeutics Inc expected to post a loss of 1 cent a share - Earnings Preview
Aclaris Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Aclaris Therapeutics Q2 Revenue USD 2.766 Million
Aclaris Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Aclaris Therapeutics Announces Sale Of Olumiant Royalties And Milestones To Omers Life Sciences For Up To $31.5 Million
U.S. STOCKS ON THE MOVE-Sigma Lithium, U.S Gold , Ballard Power
U.S. STOCKS ON THE MOVE-New York Community Bancorp, TripAdvisor, Uber
Aclaris Therapeutics falls as Q1 revenue declines
Aclaris Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: Aclaris Therapeutics Q1 Net Income USD -16.941 Million
Aclaris Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Aclaris Therapeutics Q4 Net Income USD -1.491 Million
Aclaris Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Aclaris Therapeutics Terminates Employment Of Chief Medical Officer Gail Cawkwell on Jan 31
U.S. STOCKS ON THE MOVE-Halozyme, Scorpio Tankers
U.S. STOCKS ON THE MOVE-Halozyme, Scorpio Tankers, Advanced Micro Devices
U.S. STOCKS ON THE MOVE-InMode, Carrols Restaurant, Tesla
Aclaris Therapeutics jumps on starting strategic business review
Brief: Aclaris Therapeutics AppointS Neal Walker As Interim CEO